• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Risk factors, prevention and therapy of fibrin reactions after IOL implantation].

作者信息

Müller-Jensen K, Zimmermann H

机构信息

Augenklinik des Städtischen Klinikums Karlsruhe.

出版信息

Klin Monbl Augenheilkd. 1995 Nov;207(5):287-91. doi: 10.1055/s-2008-1035380.

DOI:10.1055/s-2008-1035380
PMID:8587303
Abstract

BACKGROUND

Postoperative fibrinous reactions following the small-incision technique seem to be very rare. Problem cases can be treated with tissue Plasmin Activator.

METHOD

To investigate the new prophylactic and therapeutic possibilities the last 2,056 cataract procedures with PMMA lens implantation were statistically analyzed.

RESULTS

In 152 (7.4%) fibrin cases we observed after ECCE (n = 586) 12.8%, after phacoemulsification (PE) with sutured 6.5-mm corneoscleral incision (n = 546) 7.0% and after PE with clear corneal selfsealing 4.1-mm incision (n = 924) only 3.9% fibrinous reactions (p < 0.01). In case of ECCE the rate of fibrinous reactions amounted to 22.4% following prolonged procedures (< 50 min), while it was low as 9.5% with a short period of time (< 30 min) (p < 0.01). In 8 steroid-resistant cases we applied 25 micrograms Plasmin Activator intraocularly. The injections led to complete dissolution of the fibrinous membranes without complications.

CONCLUSION

Postoperative fibrinous reactions can be reduced statistically significantly by application of the corneal small-incision technique. The most efficient therapy is intraocular Plasmin Activator fibrinolysis.

摘要

相似文献

1
[Risk factors, prevention and therapy of fibrin reactions after IOL implantation].
Klin Monbl Augenheilkd. 1995 Nov;207(5):287-91. doi: 10.1055/s-2008-1035380.
2
[Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Ophthalmologe. 1996 Feb;93(1):49-53.
3
[Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].[组织型纤溶酶原激活剂在白内障手术后纤维蛋白膜治疗中的应用]
Klin Oczna. 1996;98(6):423-5.
4
[Effect of cataract technique and duration of surgery on fibrin reaction after IOL implantation].
Ophthalmologe. 1997 Jan;94(1):38-40. doi: 10.1007/s003470050081.
5
Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.组织型纤溶酶原激活剂用于治疗白内障手术后的眼内纤维蛋白膜。
Ger J Ophthalmol. 1995 Mar;4(2):75-9.
6
[Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Zhonghua Yan Ke Za Zhi. 1998 Jul;34(4):291-3.
7
Treatment of intracameral fibrinous membranes with tissue plasminogen activator.用组织纤溶酶原激活剂治疗前房内纤维蛋白膜。
Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):451-6.
8
Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
J Cataract Refract Surg. 2004 Aug;30(8):1727-31. doi: 10.1016/j.jcrs.2004.02.042.
9
Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.重组纤溶酶原激活剂在眼内纤维蛋白溶解中的临床应用。
Ger J Ophthalmol. 1992;1(5):354-60.
10
[Blood-aqueous barrier after phacoemulsification with posterior chamber lens implantation; foldable acrylate lens vs PMMA lens-- a clinical study on 46 eyes].[白内障超声乳化吸除联合后房型人工晶状体植入术后血-房水屏障;可折叠丙烯酸酯人工晶状体与聚甲基丙烯酸甲酯人工晶状体的比较——46只眼的临床研究]
Klin Monbl Augenheilkd. 2000 Oct;217(4):215-8. doi: 10.1055/s-2000-10351.